About 2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide
2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide (PubChem CID 155562916) has the molecular formula C30H34Br2N6O4
and a molecular weight of 702.45 g/mol. Its IUPAC name is 2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide.
Molecular Properties
| Compound Name | 2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide |
| PubChem CID | 155562916 |
| Molecular Formula | C30H34Br2N6O4 |
| Molecular Weight | 702.45 g/mol |
| Exact Mass | 700.10 |
| IUPAC Name | 2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide |
| SMILES | O=C(NCCCNCCCCNCCCNC(=O)C(=O)c1c[nH]c2ccc(Br)cc12)C(=O)c1c[nH]c2ccc(Br)cc12 |
| InChI | InChI=1S/C30H34Br2N6O4/c31-19-5-7-25-21(15-19)23(17-37-25)27(39)29(41)35-13-3-11-33-9-1-2-10-34-12-4-14-36-30(42)28(40)24-18-38-26-8-6-20(32)16-22(24)26/h5-8,15-18,33-34,37-38H,1-4,9-14H2,(H,35,41)(H,36,42) |
| InChIKey | IPJQLZKXVYYAGC-UHFFFAOYSA-N |
| XLogP | 4.21 |
| TPSA | 147.98 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 702.45 |
| LogP ≤ 5 | 4.21 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'} |
|---|
Analyze 2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide?
The IUPAC name of 2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide (CID 155562916) is 2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide.
What is the SMILES notation for 2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide?
The canonical SMILES for 2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide is O=C(NCCCNCCCCNCCCNC(=O)C(=O)c1c[nH]c2ccc(Br)cc12)C(=O)c1c[nH]c2ccc(Br)cc12.
What is the InChIKey of 2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide?
The InChIKey is IPJQLZKXVYYAGC-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H34Br2N6O4/c31-19-5-7-25-21(15-19)23(17-37-25)27(39)29(41)35-13-3-11-33-9-1-2-10-34-12-4-14-36-30(42)28(40)24-18-38-26-8-6-20(32)16-22(24)26/h5-8,15-18,33-34,37-38H,1-4,9-14H2,(H,35,41)(H,36,42).
What are the key properties of 2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide?
2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide has a molecular weight of 702.45 g/mol, XLogP of 4.21, 17 rotatable bonds, 6 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(5-bromo-1H-indol-3-yl)-N-[3-[4-[3-[[2-(5-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]butylamino]propyl]-2-oxoacetamide is sourced from PubChem (CID 155562916), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).